BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  Ex-Employees Accuse Biotech Hedge Fund Founder of Toxic Sexual Harassment Culture

  According to the report, Isaly made lewd comments to female employees, subjected them to pornographic images and made “pervasive sexist comments.”

  December 6, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  BioCapital

  4 Biotechs Facing Do-or-Die Catalysts in December

  As 2018 winds down, it’s not over for some biopharma companies.

  December 6, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Amazon Yanks Pharma License App in Maine

  Amazon didn’t immediately respond to a request for comment.

  December 6, 2017

   · 

  1 min read
• 

  Business

  Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and Others

  The Series A was led by GV, with participation from AtlasVenture, Takeda Ventures, Vertex Ventures HC, Amgen Ventures, Alexandria Venture Investments, and ShangPharma Group.

  December 6, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Amgen Employees Evacuated From Thousand Oaks Facility

  The four wildfires in Southern California are affecting tens of thousands of people.

  December 6, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Bay Area’s Carmot Lands $240M+ R&D Tie-Up With Biotech Giant Amgen

  Under the deal, Carmot will use its lead-identification technology to identify and advance novel drug leads for Parkinson’s disease and other disease areas.

  December 6, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  SoCal’s Avanir Scrutinized for Nudexta Prescriber Support Program

  Avanir is under fire after CNN filed a report showing how the company paid 500 prescribers about $14M over three years for prescribers to tout the benefits of its leading CNS drug Nuedexta.

  December 6, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  How Cambridge Biotech Akcea Teaches Its 80 Employees to Put a Human Face on Illnesses

  The company wants staffers to get a taste of life with a super-rare metabolic disorder. An actual taste.

  December 6, 2017

   · 

  1 min read
• 

  UK Science Gets More Post-Brexit Love From GlaxoSmithKline, Other Drugmakers

  The move is welcome news for Prime Minister Theresa May, who has struggled to win over large sections of industry as Britain prepares to leave the European Union.

  December 6, 2017

   · 

  1 min read
• 

  Titan Medical Seals Upsized $18M Funding Round

  The funding round brought in nearly $4 million more than it was originally expecting.

  December 6, 2017

   · 

  1 min read